Anticoagulation and in vitro fertilization and ovarian stimulation

Hematology (United States)

Volumn 2014, Issue 1, 2014, Pages 379-386

  Bates, Shannon M ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

BLOOD CLOTTING; COMPLICATION; DRUG EFFECTS; FEMALE; FERTILIZATION IN VITRO; HUMAN; OVULATION INDUCTION; THROMBOPHILIA; TREATMENT OUTCOME;

ANTICOAGULANTS; BLOOD COAGULATION; FEMALE; FERTILIZATION IN VITRO; HUMANS; OVULATION INDUCTION; THROMBOPHILIA; TREATMENT OUTCOME;

EID: 84925496702     PISSN: 15204391     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2014.1.379     Document Type: Article

References (51)

1. Akhtar MA, Sur S, Raine-Fenning N, Jayaprakasan K, Thornton JG, Quenby S. Heparin for assisted reproduction (review). Cochr Database Syst Rev. 2013;8:CD009452.
2. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, and Society for Assisted Reproductive Technology. 2011 Assisted Reproductive Technology National Summary Report. Atlanta: U.S. Department of Health and Human Services; 2013.
3. Khalaf Y, El-Toukhy T, Coomarasmay A, Kamal A, Bolton V, Braude P. Selective single blastocyst transfer reduces the multiple pregnancy rate and increases pregnancy rates: a pre-and postintervention study. BJOG. 2008;115(3):385-390.
4. Gelbaya TA, Kyrgiou M, Li TC, Stern C, Nardo LG. Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis. Human Reprod Update. 2007;13(4):357-364.
5. Canadian Fertility and Andrology Society. Human Assisted Reproduction 2013 Live Birth Rates for Canada [Media Release, September 26, 2013]. Available from: http://www.cfas.ca/index.php?option-com-content&view-article&id-1205%3Alive-birth-rates-2013&catid-929%3Apress-releases&Itemid-460. Accessed April 15, 2014.
6. Potdar N, Gelbaya TA, Konje JC, Nardo LG. Adjunct low-molecularweight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis. Human Reprod Update. 2013;19(6):674-684.
7. Di Nisio M, Rutjes AWS, Ferrante N, Tiboni GM, Cuccurullo F, Porreca E. Thrombophilia and outcomes of assisted reproduction techniques: a systematic review and meta-analysis. Blood. 2011(10);118: 2670-2678.
8. Ricci G, Bogatti P, Fischer-Tamaro L, et al. Factor V Leiden and prothrombin gene G20210A mutation and in vitro fertilization: a prospective cohort study. Hum Reprod. 2011(11);26:3068-3077.
9. Battaglia C, Larocca E, Lanzani A, Valentini M, Genazzani AR. Doppler ultrasound studies of the uterine arteries in spontaneous and IVF stimulated ovarian cycles. Gynecol Endocrinol. 1990;4(4):245-250.
10. Steer CV, Campbell S, Tan SL, et al. The use of transvaginal color flow imaging after in vitro fertilization identifies optimum uterine conditions before embryo transfer. Fertil Steril. 1992;57(2):372-376.
11. Kou HC, Hsu CC, Wang ST, Huang KE. Aspirin improves uterine blood flow in the peri-implantation period. J Formos Med Assoc. 1997;96(4): 253-257.
12. Siristatidis CS, Dodd SR, Drakeley AJ. Aspirin for in vitro fertilisation. Cochrane Database Syst Rev. 2011;8:CD004832.
13. Dentali F, Ageno W, Rezoagli E, et al. Low-dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and meta-analysis of the literature. J Thromb Haemost. 2012;10(10): 2075-2085.
14. Bohlmann MK. Effects and effectiveness of heparin in assisted reproduction. J Reprod Immunol. 2011;90(1):82-90.
15. Urman B, Ata B, Yakin K, et al. Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial. Hum Reprod. 2009;24(7):1640-1647.
16. Seshadri S, Sunkara SK, Khalaf Y, El-Toukhy T, Hamoda H. Effect of heparin on the outcome of IVF treatment: a systematic review and meta-analysis. Reprod BioMed Online. 2012;25(6):572-584.
17. Stern C, Chamley L, Norris H, Hale L, Baker HWG. A randomized, double-blind, placebo controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil Steril. 2003;80(2):376-383.
18. Kutteh WH, Yetman DL, Chantilis SJ, Crain J. Effect of antiphospholipid antibodies in women undergoing in vitro fertilization: role of heparin and aspirin. Human Reprod. 1997;12(6):1171-1175.
19. Sher G, Matzner W, Feinman M, et al. The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. Am J Reprod Immunol. 1998;40(2):74-82.
20. Sher G, Feinman M, Zouves C, et al. High fecundity rates following in vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Human Reprod. 1994;9(12):2278-2283.
21. Schenk LM, Butler L, Morris JP, et al. Heparin and aspirin treatment yields higher implantation rates in IVF patients antiphospholipid antibody seropositivity compared to untreated seronegative patients. Am Soc Reprod Med meeting. November 1996. Boston, MA. Abstract O-076.
22. Dentali F, Grandone E, Rezoagli E, Ageno W. Efficacy of low molecular weight heparin in patients undergoing fertilization or intracytoplasmic sperm injection. J Thromb Haemost. 2011;9(12):2503-2506
23. Noci I, Milanini MN, Ruggiero M, Papini F, Fuzzi B, Artini PG. Effect of dalteparin sodium administration on IVF outcome in nonthrombophilic young women: a pilot study. Reprod Biomed Online. 2011;22(6):615-620.
24. Qublan H, Amarin Z, Dabbas M, et al. Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial. Hum Fertil (Camb). 2008;11(4):246-253.
25. Berker B, Taskin S, Kahraman K, Taskin EA, Atabekoglu C, Sonmezer M. The role of low-molecular-weight heparin in recurrent implantation failure: a prospective, quasi-randomized, controlled study. Fertil Steril. 2011;95(8):2499-2502.
26. Joint Society of Obstetricians and Gynaecologists of Canada-Canadian Fertility Andrology Society Clinical Practice Guidelines Committee; Reproductive Endocrinology and Infertility Committee of the SOGC; Executive and Council of the Society of Obstetricians; Gynaecologists of Canada; Board of the Canadian Fertility and Andrology Society, Shmorgun D, Claman P. The diagnosis and management of ovarian hyperstimulation syndrome. J Obstet Gynaecol Can. 2011;268(11):1156-1162.
27. Golan A, Ron-El R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv. 1989;44(6):430-440.
28. Serour GI, Aboulghar M, Mansour R, Sattar MA, Amin Y, Aboulghar H. Complications of medically assisted conception in 3500 cycles. Fertil Steril. 1998;70(4):638-642.
29. Mathur R, Kailasam C, Jenkins J. Review of the evidence base strategies to prevent ovarian hyperstimulation syndrome. Hum Fertil. 2007;10(2):75-85.
30. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril. 1992;58(2):249-261.
31. Nelson SM. Venous thrombosis during assisted reproduction: novel risk reduction strategies. Thromb Res. 2013;131(Suppl 1):S1-S3.
32. Dulitzky M, Cohen SB, Inbal A, et al. Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome. Fertil Steril. 2002;77(3):463-467.
33. Fabregues F, Tassies D, Reverter JC, Carmona F, Ordinas A, Balasch J. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening. Fertil Steril. 2004;81(4):989-995.
34. Machac S, Lubusky M, Prochazka M, Streda R. Prevalence of inherited thrombophilia in patients with severe ovarian stimulation. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006;150(2):289-292.
35. Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010;149(2):209-220.
36. Mára M, Koryntová D, Rezábek K, et al. Thromboembolic complications in patients undergoing in vitro fertilization: retrospective clinical study. Ceska Gynecol. 2004; 69(4):312-316.
37. Aurousseau MH, Samama MM, Belhassen A, Herve F, Hugues JN. Risk of thromboembolism in relation to an in vitro fertilization programme: three case reports. Hum Reprod. 1995; 10(1):94-97.
38. Rova K, Passmark H, Lindqvist PG. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in successful cycles. Fertil Steril. 2012;979(1): 95-100.
39. Henriksson P, Westerlund E, Wallen H, Brandt L, Hovatta O, Ekbom A. Incidence of pulmonary embolism and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ. 2013;346:e8632. doi:10.1136/bmj.e8632.
40. Jacobsen AF, Skjeldestad FE, Sandset PM. Ante and postnatal risk factors of venous thrombosis: a hospital-based control-study. J Thromb Haemost. 2008; 6(6):905-912.
41. Hansen AT, Kesmodel US, Juul S, Hvas AM. Increased venous thrombosis incidence in pregnancies after in vitro fertilization. Hum Reprod. 2014;29(3):611-617.
42. Chan WS. The "ART" of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol. 2009; 21(3):207-218.
43. ESHRE Capri Workshop Group. Venous thromboembolism in women: a specific reproductive risk. Hum Reprod Update. 2013;19(5):471-482.
44. Bauersachs RM, Manolopoulos K, Hoppe I, Arin MJ, Schleussner E. More on: the "ART" behind the clot: solving the mystery. J Thromb Haemost. 2007;5(2):438-439.
45. Salomon O, Schiby G, Heiman Z, et al. Combined jugular and subclavian vein thrombosis following assisted reproductive techology -new observation. Fertil Steril. 2009;92(2):620-625.
46. Yinon Y, Pauzner R, Dulitzky M, Elizur SE, Dor J, Shulman A. Safety of IVF under anticoagulant therapy in patients at risk for thromboembolic events. Reprod Biomed Online. 2006;12(3):354-358.
47. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO; American College of Chest Physicians. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl):e691S-e736S.
48. The Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome educational bulletin. Fertil Steril. 2008;90(5 Suppl):S188-193.
49. Royal College of Obstetricians and Gynecologists. Green-top Guideline No. 37a: Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. November 2009; 1-35.
50. The Practice Committee of the American Society for Reproductive Medicine. Antiphospholipid antibodies do not affect IVF success. Fertil Steril. 2008;90(5 Suppl):S172-S173.
51. Guyatt G, Vist G, Falck-Ytter Y, Kunz R, Magrini N, Schunemann H. An emerging consensus on grading recommendations? ACP J Club. 2006;155(1):A8-A9.